Electronic Data Capture for Oncology Trials Built for Complex Endpoints

Electronic data capture in oncology is not a commodity function. Oncology trials generate complex datasets — response assessments, tumor measurements, biomarker results, patient-reported outcomes, concomitant medication records for patients on multiple agents — that require EDC systems configured with oncology-specific data standards and edit logic.

Sitero’s EDC module, part of the Mentor eClinical platform, supports the data complexity that oncology programs routinely generate.

Planning an oncology trial? Sitero has supported 200+ studies across 67+ countries.

Learn more

Oncology-Specific Data Requirements

Response assessment in oncology — whether RECIST, iRECIST, or disease-specific criteria — requires structured data capture that reflects the measurement and calculation rules of the assessment methodology. Generic EDC forms adapted from non-oncology studies introduce data quality risk. Sitero’s data management team builds EDC specifications for oncology endpoints, including response assessment forms, CTCAE adverse event grading, and biomarker data fields designed for the protocol, not repurposed from a template.

Multi-Arm and Adaptive Data Structures

Multi-arm trials, basket studies, and adaptive designs require EDC configurations that accommodate arm-specific data collection, cohort-level data views, and mid-study protocol changes without compromising database integrity. Sitero’s EDC supports these structures with amendment management processes that update data collection instruments cleanly when protocols change.

Biomarker Data Integration

For biomarker-driven programs, EDC must capture results from central labs, local labs, and companion diagnostics in a structured, analysis-ready format. Sitero coordinates between data management and laboratory operations to ensure biomarker data flows into the trial dataset accurately, with appropriate source verification and query management.

Data Quality and Closeout Efficiency

Clean data at interim and final analysis is a direct function of how well data review is managed throughout the trial. Sitero’s data management team runs ongoing data review against defined quality thresholds, resolving queries in real time rather than accumulating them for end-of-study remediation. Across Sitero’s oncology programs, this approach has contributed to a 60% decrease in data management closeout timelines.

Real-Time Reporting for Oversight

Sitero’s EDC integrates with real-time reporting and insights tools, giving sponsor teams visibility into enrollment status, data entry completeness, query metrics, and protocol deviation trends — operational intelligence that matters at interim analyses and DSMB reviews.

Supporting Sponsor Oversight

Sponsor oversight of EDC operations in oncology requires more than periodic data listings. Sitero’s real-time reporting tools give sponsor teams direct visibility into site-level data entry rates, query aging, protocol deviation trends, and enrollment against plan — the operational intelligence needed to intervene early when data quality or site performance issues emerge. This transparency is built into the standard service model, not provided as an add-on.

Frequently Asked Questions

How does Sitero configure EDC for oncology-specific endpoints like RECIST?

Sitero’s data management team builds EDC specifications from the protocol up, including structured response assessment forms configured to the relevant assessment criteria (RECIST 1.1, iRECIST, or disease-specific scales), CTCAE grading forms, and biomarker data capture fields — not adapted from a generic oncology template.

How does Sitero handle EDC updates when oncology protocols are amended?

Sitero’s EDC amendment management process updates data collection instruments in response to protocol changes while maintaining database integrity and a clear audit trail. Arm-specific configurations in multi-arm trials can be updated independently without disrupting other arms.

What real-time reporting does Sitero provide for oncology EDC data?

Sitero’s EDC integrates with real-time reporting dashboards that provide sponsor visibility into enrollment, data entry status, query metrics, and protocol deviations. This supports operational decision-making between DSMB reviews and provides early warning of data quality issues before they affect interim analysis timelines.

Ready to discuss your oncology program?

Sitero combines full-service CRO capabilities with integrated eClinical technology — purpose-built for complex oncology trials.

Talk to an Oncology Trial Expert